Camber Launches Generic Prozac®
Piscataway, NJ, December 8, 2015– Camber Pharmaceuticals is pleased to announce the addition of Fluoxetine capsules to our growing portfolio of products.
Fluoxetine capsules are the generic version of Prozac® capsules. Fluoxetine capsules are used to treat major depressive disorder, bulimia nervosa, obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder (PMDD). Fluoxetine capsules are available in 10 mg, 20 mg, 40 mg in both 30 and 100 count bottles.
Camber’s commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection